- Home
- / Hoth Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Hoth Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1
2024-10-29
Market Capitalization
$6.7 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 03, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|
| General and administrative expense | 1.2M | 984.8K | 4.2M | 5.0M | 6.4M | ||||
| Operating expense total | 1.9M | 785.3K | 2.0M | 2.3M | 5.8M | 7.7M | 8.2M | 12.4M | |
| EBIT | (1.9M) | (2.5M) | (7.7M) | (7.3M) | (14.1M) | (11.1M) | (7.7M) | (8.2M) | (12.4M) |
| Investment income | (377.0K) | ||||||||
| Interest income | 10.6K | 104.2K | 6.4K | 781.0 | |||||
| Interest expense | 144.0K | 10.4K | |||||||
| Pre tax profit | (12.4M) | ||||||||
| Income tax expense | 417.8K | 1.7M | 1.5M | (548.7K) | |||||
| Net Income | (2.0M) | (2.5M) | (7.7M) | (7.2M) | (14.3M) | (11.4M) | (7.8M) | (8.2M) | (12.5M) |
| EPS | (8.8) | (2.3) | (1.3) | (0.9) |